Operating Lease, Right-of-Use Asset of Acadia Healthcare Company, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Acadia Healthcare Company, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Acadia Healthcare Company, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $114,248,000, a 6.9% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Acadia Healthcare Company, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $114,248,000 -$8,523,000 -6.9% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $112,743,000 -$10,530,000 -8.5% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $120,701,000 -$645,000 -0.53% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $118,369,000 +$589,000 +0.5% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $122,771,000 +$681,000 +0.56% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $123,273,000 -$4,242,000 -3.3% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $121,346,000 -$11,932,000 -9% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $117,780,000 -$17,458,000 -13% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $122,090,000 -$13,537,000 -10% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $127,515,000 -$9,980,000 -7.3% 30 Jun 2023 10-Q 28 Jul 2023 2023 Q2
Q1 2023 $133,278,000 -$5,986,000 -4.3% 31 Mar 2023 10-Q 27 Apr 2023 2023 Q1
Q4 2022 $135,238,000 +$1,477,000 +1.1% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $135,627,000 +$32,465,000 +31% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $137,495,000 +$35,804,000 +35% 30 Jun 2022 10-Q 28 Jul 2022 2022 Q2
Q1 2022 $139,264,000 +$43,059,000 +45% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $133,761,000 +$36,824,000 +38% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $103,162,000 -$361,434,000 -78% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $101,691,000 -$373,571,000 -79% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $96,205,000 -$379,823,000 -80% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $96,937,000 -$858,000 -0.88% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $464,596,000 -$15,285,000 -3.2% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $475,262,000 -$16,289,000 -3.3% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $476,028,000 -$30,759,000 -6.1% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 $97,795,000 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $479,881,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $491,551,000 30 Jun 2019 10-Q 31 Jul 2019 2019 Q2
Q1 2019 $506,787,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.